Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Release & Stability Testing Requirements for Parenteral Drug Products | Contract Pharma

Release & Stability Testing Requirements for Parenteral Drug Products

Parenteral products are sterile drugs, solutions, emulsions and suspensions. Parenteral products are unique from any other type of pharmaceutical dosage form for the following reasons: All products must be sterile and free from pyrogenic (endotoxin) contamination.

Release and stability testing are a vital part of new drug development and is conducted throughout a product’s life cycle. These studies confirm that the quality, safety, and effectiveness of drug products are preserved all through the shelf life as an essential requirement. This presentation will provide a brief overview of the parenteral drug products release testing as well as the ICH guidelines for stability testing.


Register Now!
Warning: Undefined variable $featured_post in /var/www/html/wp-content/themes/RodmanMediaCore/single-webinar.php on line 216 Warning: Attempt to read property "ID" on null in /var/www/html/wp-content/themes/RodmanMediaCore/single-webinar.php on line 216